2021 Session III

Session III: September 22, 2021

Enhancing Early Detection, Treatments and Clinical Trials Education

Innovative tools and approaches to enhance patient education have been developed and launched by PHEN. These include Dr. PSA for early detection screening, PHENPath.com for treatments, and the Clinical Trials Rally II initiative. Each facilitates informed shared decision – making by empowering both patients and doctors. This session reviewed strategies and outcomes using these tools and approaches.

Prior Summit Images

The Importance of Early Detection Screening and Why It Is Extremely Important for Black Men.   Watch Video

Keith Crawford, MD, PhD, PHEN Director of Clinical Trials and Patient Education

Early Detection Screening Education and Patient Portal:

The Incorporation of The PHEN Early Detection Screening Program into The Community Outreach, Engagement and Equity Program at Duke Cancer Institute Watch Video

Angelo Moore, PhD, RN, NE-BC, Program Manager, Office of Health Equity, Duke Cancer Institute

The Incorporation of The PHEN Early Detection Screening Program Into The Luminis Healthcare System  Watch Video

Waseem Hussain, MD, Associate Regional Medical Director of Primary Care, Luminis Healthcare System

A Discussion of his Prostate Cancer Journey and The Importance of Early Detection Screening     Watch Video

Rausan Battle, Survivor

Treatment Education and Patient Portal:

Considerations for the Management of Advanced Prostate Cancer    Watch Video

 Jacob Berchuck, MD, Medical Oncologist, Dana-Farber Cancer Institute

Phenpath.com Helps Guide Patients Through the Complicated Prostate Cancer Treatment Options   Watch Video

Emerson ‘Randy’ Hall, Jr., PhD, Survivor

PHENpath.Com Helped Him Better Understand The Variety Of Treatment Options Available For His Brother    Watch Video

Mr. Rodney Palmer, Caregiver

Clinical Trials Strategies to Increase Patient Accrual:

Prostate Cancer Treatments: The Importance of Clinical Trials     Watch Video

Elisabeth I. Heath, MD, FACP, Associate Center Director of Translational Sciences, Karmanos Cancer Institute

The Perspective of Prostate Cancer Through The Lens of A Doctor And Prostate Cancer Survivor     Watch Video

Jackson L. Davis, III, MD, Brig. Gen. USAF (Ret), Medical Doctor and Survivor

Special Presentations

Variance in Symptom Assessment Between Patient and Caregiver    Watch Video

 Jay Jhaveri, MD, MPH, Director, Medical Affairs Oncology, Bayer

Next Generation Precision Radiopharmaceuticals for Patients with Cancer    Watch Video

Ms. Ann Marie Dawidczyk, Vice President Patient Access and Advocacy, Blue Earth Diagnostics

The Importance of Genetic Testing      Watch Video

Todd Cohen, MD and Keith Crawford, MD, PhD

Session Participants

Mr. Thomas Farrington

Mr. Thomas Farrington

Keith Crawford, MD, PhD

Keith Crawford, MD, PhD

Angelo Moore, PhD, RN, NE-BC

Angelo Moore, PhD, RN, NE-BC

Waseem Hussain, MD

Waseem Hussain, MD

Mr. Rausan Battle

Mr. Rausan Battle

Jacob Berchuck, MD

Jacob Berchuck, MD

Emerson 'Randy' Hall, Jr., PhD

Emerson 'Randy' Hall, Jr., PhD

Mr. Rodney Palmer

Mr. Rodney Palmer

Elisabeth I. Heath, MD, FACP

Elisabeth I. Heath, MD, FACP

Jackson L. Davis, III, MD

Jackson L. Davis, III, MD

Jay Jhaveri, MD, MPH

Jay Jhaveri, MD, MPH

Ms. Ann Marie Dawidczyk

Ms. Ann Marie Dawidczyk